A joint task force of the European Association of Nuclear Medicine (EANM) and the European Academy of Neurology (EAN) has released new guidelines concerning the use of FDG-PET for neurodegenerative disorders.
The mixed panel of EANM and EAN members completed a literature review and an investigation with the Delphi method to identify information about proper FDG-PET use missing from international literature.
Intended to cover these gaps, the new recommendations have been published in the European Journal of Neurology (22 June 2018), with a special issue in the European Journal of Nuclear Medicine and Molecular Imaging (July 2018, Vol. 45:9, pp. 1467-1644) dedicated to discussing them.
